Pressure cuff treatment effective for heart patients
This article was originally published in Clinica
Heart disease patients whose blood flow is boosted by pressurised cuffs wrapped around their legs experience fewer adverse events than a similar group treated with drugs, says Vasomedical the US company behind the non-surgical procedure. During the treatment, called enhanced external counterpulsation (EECP), the pressurised cuffs are repeatedly inflated and deflated in time with the patient's beating heart.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.